Dental caries
Drug research and approvals for dental caries: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 75 studies of dental caries are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.
- Recruiting worldwide: 75
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Silver Diamine Fluoride for Caries in Primary Teeth in Routine Clinical PracticeNCT07926828 · Not reported · Consorci Sanitari de l'Alt Penedès i Garraf · starts Sep 17, 2026
- Comparison of Intraoperative Pain Perception During Caries Excavation Using Smart Burs and Carisolv to Conventional…NCT07869407 · Not applicable · Rehman Medical Institute - RMI · starts Jul 1, 2026
- A Study to Evaluate the Cariostatic Efficacy of Nano Silver Fluoride (NSF) vs. Silver Diamine Fluoride (SDF) in ChildrenNCT07861321 · Not applicable · A.T. Still University of Health Sciences · starts Oct 1, 2026
- Powered vs Manual Toothbrush Use: Its Effect on Caries Risk in Pre-AdolescentsNCT07859553 · Not applicable · University of Michigan · starts Oct 28, 2026
- Clinical Performance and Failure Rates of Restorations Following Pediatric Dental Rehabilitation Under General…NCT07827833 · Not reported · Tanta University · starts Aug 3, 2025
- Clinical Investigation of the Performance of Epinamel for Dental White Spot LesionsNCT07730359 · Not applicable · Mintech Bio Ltd · starts Jul 6, 2026
- Validation of a Digital Caries Risk Assessment Questionnaire Against the CAMBRA Protocol in an Egyptian Adult PopulationNCT07716254 · Not reported · October University for Modern Sciences and Arts · starts Jun 5, 2026
- Remineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium…NCT07711132 · Not applicable · Mansoura University · starts Dec 20, 2025
- Clinical and Radiographic Assessment of First Permanent Molars With Cention-NNCT07703176 · Not applicable · Minia University · starts Mar 9, 2026
Phase 3 9
Phase 2 5
- C16G2Cell membrane disrupting agent
- Calcium phosphate, tribasic
- Aloe
- Licorice
- Propolis wax
Phase 1 or earlier 7
- SimvastatinHMG-CoA reductase inhibitor
- NystatinErgosterol sequestering agent
- Tolonium
- Calcium glycerophosphate
- Hydrogen peroxide
- Calcium carbonate
- Hydrazine
How its trials ended
963 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 114 whose ending is known, 62% met their primary endpoint, 9% missed it and 29% stopped early.
- Completed, result not reported45647%
- Status unknown21522%
- Ongoing17818%
- Met its primary endpoint717%
- Stopped: other or unclear263%
- Missed its primary endpoint101%
- Stopped: enrollment or feasibility3<1%
- Stopped: lack of efficacy2<1%
- Stopped: sponsor or business decision2<1%
| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Jul 31, 2001 | Intraoral fluoride releasing systemPrevention of dental caries due to radiation-induced xerostomia in patients with head and neck cancer | Digestive Care, Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA